Haichun Huang

USPTO Granted Patents = 80 (Patent Applications = 37)

CIPO Patents = 16 (Patent Applications = 17)

EPO Patents = 34 (Patent Applications = 51)

Average Co-Inventor Count = 7.3

ph-index = 22

Forward Citations = 2,376(Granted Patents)

Forward Citations (Not Self Cited) = 2,276(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Fremont Park, CA (US) (2013)
Freemont, CA (US) (2015)
San Carlos, CA (US) (2014 - 2019)
Fremont, CA (US) (2008 - 2023)

Company Filing History:

29 out of 3,684

Bristol-myers Squibb Compnay

E. R. Squibb Sons, Inc.

Ono Pharmaceutical Co., Ltd.

patents

7. 3 out of 3

Novarock Biotherapeutics, Ltd.

patents

8. 2 out of 18

Oxford Biotherapeutics Ltd

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

Tumor Necrosis Factor

Interleukin-23

Glypican-3

Programmed Death Ligand 1

Cancer Diagnostics

OX40 Receptor

CD73 Antibodies

B7RP1 Neutralizing Antibodies

Nerve Growth Factor

GITR Antibodies

IL-6 Antibodies

80 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12372536 - Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof (2025-07-29),

2. 12365727 - Anti-interleukin-23 P19 antibodies and methods of use thereof (2025-07-22),

3. 12110337 - Anti-CD27 antibodies and uses thereof (2024-10-08),

4. 11802162 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2023-10-31),

5. 11474112 - Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof (2022-10-18),

6. 11408889 - Anti-GITR antibodies for cancer diagnostics (2022-08-09),

7. 11407828 - Anti-CLauDiN 18 antibodies and methods of use thereof (2022-08-09),

8. 11396541 - Anti-interleukin-23 P19 antibodies and methods of use thereof (2022-07-26),

9. 11352440 - Antibodies against CD73 and uses thereof (2022-06-07),

10. 11242393 - Antibodies against MICA and/or MICB and uses thereof (2022-02-08),

11. 11213586 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) (2022-01-04),

12. 11084881 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2021-08-10),

13. 10690674 - Anti-GITR antibodies for cancer diagnostics (2020-06-23),

14. 10501550 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2019-12-10),

15. 10465010 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2019-11-05),

Title: Haichun Huang - Pioneering Inventor from Fremont, CA

Introduction: Haichun Huang is a renowned inventor based in Fremont, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Haichun Huang holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Haichun Huang has worked with leading tech companies, research institutions, and universities, where he has spearheaded numerous projects that have revolutionized the industry.

Collaborations: Throughout his career, Haichun Huang has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and knowledge sharing that has led to significant advancements in various fields.

Conclusion: Haichun Huang's passion for innovation, coupled with his relentless drive to push the boundaries of technology, has solidified his reputation as a visionary inventor whose work continues to inspire and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.